General

Sands Aims To Invest $200M In Workforce Development Over Next Five Years

https://www.accesswire.com/732811/Sands-Aims-To-Invest-200-Million-in-Workforce-Development-Over-the-Next-Five-Years-To-Support-Professional-Growth-and-Pathways-to-Prosperity

byBenzinga Newsdesk

December 21, 2022

1 minute read

https://www.accesswire.com/732811/Sands-Aims-To-Invest-200-Million-in-Workforce-Development-Over-the-Next-Five-Years-To-Support-Professional-Growth-and-Pathways-to-Prosperity

American Airlines Sought JetBlue Alliance For Economic Survival During COVID-19: Report

By Shivani Kumaresan

October 4, 8:11 AM

American Airlines Group Inc (NASDAQ: AAL) pursued an alliance with JetBlue Airways Corp (NASDAQ: JBLU) in order to stay afloat during the COVID-19 pandemic-induced economic uncertainty.

AAL

Lexaria Bioscience Corp. Releases Results Of Human Clinical Study Showing Effective, Safe BP Reduction With CBD

By InvestorBrandNetwork

September 7, 12:17 PM

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has announced that its human clinical study HYPER-H21-2, which features LEXX’s patented DehydraTECH(TM)-processed cannabidiol (&l

LEXX

Angion and Vifor Pharma Report Topline Results From Phase 2 GUARD Trial Of ANG-3777 In Cardiac Surgery-Associated Acute Kidney Injury

By Benzinga Newsdesk

December 9, 5:10 PM

Angion Biomedica Corp. (NASDAQ:ANGN) and Vifor Pharma today announced results from the exploratory Phase 2 GUARD trial of Angion's ANG-3777 in patients undergoing cardiac surgery involving cardiopulmonary bypass at

ANGN

As Mortgage Demand Is Slashed Due To Rising Rates, So Are The Valuations Of These Companies

By AJ Fabino

July 20, 7:45 PM

Between June 10 and 17, 11 publicly traded mortgage companies saw their market value decline by a combined $6.14 billion.

COOP

Sands Aims To Invest $200M In Workforce Development Over Next Five Years

Related Posts

American Airlines Sought JetBlue Alliance For Economic Survival During COVID-19: Report

Lexaria Bioscience Corp. Releases Results Of Human Clinical Study Showing Effective, Safe BP Reduction With CBD

Angion and Vifor Pharma Report Topline Results From Phase 2 GUARD Trial Of ANG-3777 In Cardiac Surgery-Associated Acute Kidney Injury

As Mortgage Demand Is Slashed Due To Rising Rates, So Are The Valuations Of These Companies